MMedication Read More Paxton makes “extraordinary request” to block Tylenol maker from paying shareholdersNovember 7, 2025 by Eleanor Klibanoff, The Texas Tribune November 6, 2025 Texas Attorney General Ken Paxton is asking a judge…
MMedication Read More Pharmacy settles lawsuit over counterfeit Ozempic salesNovember 7, 2025 IOWA’S NEWS LEADER. KAYLA. THANKS. NEW AT SIX, A PHARMACY IN EASTERN IOWA ACCUSED OF SELLING COUNTERFEIT OZEMPIC…
MMedication Read More RFK Jr. stands by his position on Tylenol for pregnant womenNovember 7, 2025 RFK Jr. says ‘not sufficient’ proof linking Tylenol and autism Health Secretary Robert F. Kennedy Jr. told reporters…
MMedication Read More Nationwide ADHD Medication Recall Update as FDA Sets Risk LevelNovember 7, 2025 A voluntary, nationwide recall of Lisdexamfetamine dimesylate capsules, a drug often used to treat Attention Deficit Hyperactivity Disorder…
MMedication Read More FDA Approves Caplyta for Adjunctive Treatment of Major Depressive DisorderNovember 7, 2025 The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s lumateprone (Caplyta) as an adjunctive therapy for…
MMedication Read More Texas AG Ken Paxton moves to block Tylenol maker dividend amid lawsuit over marketingNovember 7, 2025 Texas Attorney General Ken Paxton has filed a motion to block Kenvue, the maker of Tylenol, from issuing…
MMedication Read More Drug company representative collapses during Oval Office eventNovember 6, 2025 A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President…
MMedication Read More Weight loss gets cheaper: New White House deal slashes prices of Ozempic and Wegovy |November 6, 2025 The cost of some of the most widely used weight loss medications in the United States is set…
MMedication Read More Suburban chiropractor accused of secretly recording more than 100 patientsNovember 6, 2025 ST. CHARLES, Ill. (WGN) — A west suburban chiropractor is accused of secretly video taping his patients as…
MMedication Read More Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s StelaraNovember 6, 2025 In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
MMedication Read More New FDA priority review vouchers go to Lilly, Novo, VertexNovember 6, 2025 WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
MMedication Read More Trump inks deals to cut prices of weight loss drugsNovember 6, 2025 The Trump Administration announced on Thursday that it has reached deals with Eli Lilly and Novo Nordisk to lower…